Shilp Shah received his B.S. in Bioengineering from UCLA in 2024, and is now pursuing a medical degree. He is currently working as a Clinical Research Coordinator at Stanford from 2024–2025, investigating cognition in Neurofibromatosis Type 1 children. His research topics mainly include: cancer predisposition syndromes, nanomedicine therapeutics, and lab-on-a-chip technology.
Dr. Marco Giovannini is a Professor in Residence at the Department of Head and Neck Surgery, University of California Los Angeles—UCLA, USA. He is also the Director of the Neural Tumor Research Laboratory. He earned his PhD in Cytomorphology from Alma Mater Studiorum, Università di Bologna, Italy, and an HDR in Molecular Genetics from the Université Paris Cité. The long-term interest of his research laboratory is the genetics and biology of human cancer predisposition and progression. His laboratory has made several seminal contributions to the characterization of major tumor suppressors such as NF1, NF2, p53, APC, and SMARCB1.
